Search results for "Stomatitis"

showing 6 items of 136 documents

Effect of probiotics as a complement to non-surgical periodontal therapy in chronic periodontitis : a systematic review

2020

Background To improve the results of the classic periodontal treatment, probiotics have been suggested recently to decrease the number of bacteria and the expression of mediators of inflammation. This systematic review aimed to assess the literature for the effectiveness of different probiotic strains as adjuvants to non-surgical periodontal therapy. Material and Methods The electronic database of MEDLINE (via Pubmed) was searched up to December 2017 for randomised clinical trials in English comparing non-surgical periodontal treatment and probiotics versus periodontal treatment and placebo. The primary outcome investigated was reduction in pocket probing depth. Secondary outcomes were blee…

medicine.medical_specialtymedicine.medical_treatmentBleeding on probingDental PlaqueReviewMalalties de la bocaPlaceboDental plaqueMalalties de l'estómac03 medical and health sciences0302 clinical medicineInternal medicinemedicineMucositisHumansPeriodontologyPeriodontitisGeneral DentistryStomatitisbusiness.industryProbioticsDental Plaque Index030206 dentistrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]Chronic periodontitisProbiòticsDental Plaque IndexClinical trialMouth diseasesOtorhinolaryngologyDebridement (dental)Chronic PeriodontitisUNESCO::CIENCIAS MÉDICASDental ScalingSurgerymedicine.symptombusinessStomach diseases
researchProduct

RANDOMIZED PHASE II STUDY OF FIRST-LINE EVEROLIMUS (EVE) + BEVACIZUMAB (BEV) VERSUS INTERFERON ALFA-2A (IFN) + BEV IN PATIENTS (PTS) WITH METASTATIC …

2012

ABSTRACT Background Study results demonstrated that IFN augments BEV activity and improves median PFS in pts with mRCC. Thus, combination BEV + IFN is a standard first-line treatment option for mRCC. Combining BEV with the mTOR inhibitor EVE may be an efficacious and well-tolerated treatment option. The open-label, phase II RECORD-2 trial compared first-line EVE + BEV and IFN + BEV in mRCC. Patients and methods: Therapy-naive pts with clear cell mRCC and prior nephrectomy were randomized 1:1 to BEV 10 mg/kg IV every 2 weeks with either EVE 10 mg oral daily or IFN (9 MIU SC 3 times/week, if tolerated). Tumour assessments were every 12 weeks. Primary objective was treatment effect on progress…

medicine.medical_specialtymedicine.medical_treatmentGastroenterology03 medical and health sciences0302 clinical medicineProstateInternal medicinemedicineStomatitisObjective response030304 developmental biology0303 health sciencesProteinuriaGenitourinary systembusiness.industryTreatment optionsHematologymedicine.diseaseNephrectomy3. Good healthmedicine.anatomical_structureOncologyTolerability030220 oncology & carcinogenesismedicine.symptombusinessAnnals of Oncology
researchProduct

Experimental evolution of an RNA virus in cells with innate immunity defects

2015

Experimental evolution studies have shown that RNA viruses respond rapidly to directional selection and thus can adapt efficiently to changes in host cell tropism, antiviral drugs, or other imposed selective pressures. However, the evolution of RNA viruses under relaxed selection has been less extensively explored. Here, we evolved vesicular stomatitis virus in mouse embryonic fibroblasts knocked-out for PKR, a protein with a central role in antiviral innate immunity. Vesicular stomatitis virus adapted to PKR-negative mouse embryonic fibroblasts in a gene-specific manner, since the evolved viruses exhibited little or no fitness improvement in PKR-positive cells. Full-length sequencing revea…

parallel evolutionepistasisvirusesMutagenesis (molecular biology technique)Microbiology03 medical and health sciencesVirologyexperimental evolutionTropismattenuation030304 developmental biologyGenetics0303 health sciencesExperimental evolutionInnate immune systembiology030306 microbiology030302 biochemistry & molecular biologyRNARNA virusPKRbiology.organism_classificationVesicular stomatitis virusViral evolutionvesicular stomatitis virusCorrigendumResearch ArticleVirus Evolution
researchProduct

Prevalence of aphthous stomatitis in patients with inflammatory bowel disease after the treatment with monoclonal antibodies: a systematic review and…

2022

Currently, the most frequently employed therapies in the treatment of inflammatory bowel diseases (IBD), i.e., Crohn's Disease (CD), Ulcerative Colitis (UC) or unclassified IBD (IBD-U) are monoclonal anti-TNFs and anti-integrin therapies, such as vedolizumab (VDZ). Forty-seven per cent of these patients present extra-intestinal manifestations, the second most prevalent being aphthous stomatitis (AS). The present study aims to investigate which of the two therapies is associated with a lower prevalence of AS after treatment. An electronic search of the MEDLINE (via PubMed), Web of Science, SCOPUS, LILACS and OpenGrey databases was carried out. The criteria used were those described by the PR…

spatial analysisAntibodies Monoclonaloral cancerInflammatory Bowel DiseasesCrohn DiseaseOtorhinolaryngologydeathPrevalenceHumansStomatitis AphthousTumor Necrosis Factor InhibitorsColitis UlcerativeSurgeryGeneral DentistryUNESCO:CIENCIAS MÉDICAShospitalizationMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Asociación entre alteraciones psicológicas y la presencia de Liquen plano oral, Síndrome boca urente y Estomatitis aftosa recividante

2004

OBJETIVO: El propósito de este estudio fue determinar la relación existente entre el Liquen Plano Oral (LPO),Estomatitis Aftosa Recividante (EAR), Síndrome de Boca Urente (SBU) y las alteraciones psicológicas del paciente, tales como el estrés, la ansiedad y la depresión. DISEÑO DEL ESTUDIO : Fueron estudiados 18 pacientes con EAR , 9 pacientes con LPO y 7 pacientes con SBU, que presentaron la lesión en el momento del examen, más un grupo control de 20 pacientes sanos. Ambos grupos fueron extraídos de centros hospitalarios y docentes, donde el diagnóstico clínico fue realizado por un equipo de patólogos orales. A los pacientes se les aplicó dos instrumentos de medición del estado psicológic…

stomatognathic diseasesestrésUNESCO::CIENCIAS MÉDICASEstomatitis aftosa recividante (EAR)depresiónOdontologíaansiedadsíndrome boca urente (SBU):CIENCIAS MÉDICAS [UNESCO]liquen plano oral (LPO)Ciencias de la salud
researchProduct

Tumor targeting of baculovirus displaying a lymphatic homing peptide.

2008

Background Tumor-associated cells and vasculature express attractive molecular markers for site-specific vector targeting. To attain tumor-selective tropism, we recently developed a baculovirus vector displaying the lymphatic homing peptide LyP-1, originally identified by ex vivo/in vivo screening of phage display libraries, on the viral envelope by fusion to the transmembrane anchor of vesicular stomatitis virus G-protein. Methods In the present study, we explored the specificity and kinetics of viral binding and internalization as well as in vivo tumor homing of the LyP-1 displaying virus to elucidate the applicability of baculovirus for targeted therapies. Results We demonstrated that th…

virusesmedia_common.quotation_subjectGenetic VectorsMice NudeBiologyPeptides CyclicVirus03 medical and health sciencesTransduction (genetics)Mice0302 clinical medicineViral envelopeViral Envelope ProteinsIn vivoTransduction GeneticCell Line TumorNeoplasmsDrug DiscoveryGeneticsAnimalsHumansTransgenesInternalizationMolecular BiologyGenetics (clinical)030304 developmental biologymedia_commonLymphatic Vessels0303 health sciencesBinding SitesMembrane GlycoproteinsGene Transfer TechniquesGenetic Therapybiology.organism_classificationMolecular biology3. Good healthCell biologyVesicular stomatitis virus030220 oncology & carcinogenesisMolecular MedicineBaculoviridaeEx vivoHoming (hematopoietic)The journal of gene medicine
researchProduct